Repligen (RGEN) Consolidated Net Income (2010 - 2026)
Repligen's (RGEN) quarterly Consolidated Net Income came in at $8.4 million in Q1 2026, up 43.6% year-on-year from $5.8 million in Q1 2025, and down 37.17% on a QoQ basis from $13.3 million in Q4 2025.
Repligen (RGEN) Consolidated Net Income (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Consolidated Net Income data on file, last reported at $8.4 million in Q1 2026.
- On a quarterly basis, Consolidated Net Income rose 43.6% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $51.5 million, a 232.93% increase from a year earlier, with the FY2025 full-year figure at $48.9 million, up 218.51% from the prior year.
- Consolidated Net Income for Q1 2026 stood at $8.4 million, down from $13.3 million in the prior quarter.
- Over the last five years, Consolidated Net Income for RGEN reached as high as $81.9 million in Q4 2022 and fell as low as -$49.6 million in Q4 2024.
- Historically, Consolidated Net Income has averaged $17.2 million across 5 years, with a median of $14.9 million in 2025.
- Across the five-year window, Consolidated Net Income plunged 1164.41% in 2024 and surged 2380.12% in 2025, its largest moves.
- Year by year, Consolidated Net Income stood at $81.9 million in 2022, then slumped by 94.31% to $4.7 million in 2023, then plunged by 1164.41% to -$49.6 million in 2024, then surged by 126.86% to $13.3 million in 2025, then sank by 37.17% to $8.4 million in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were $8.4 million in Q1 2026, $13.3 million in Q4 2025, and $14.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.53 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.95 Bn | 44.14 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 33.20 Bn | 31.54 Bn | 1.53 Bn | 240.00 Mn |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.49 Bn | 27.83 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.32 Bn | 22.89 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.08 Bn | 13.51 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.86 Bn | 13.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.11 Bn | 11.05 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Repligen | 7.45 Bn | 6.47 Bn | 108.28 Mn | 8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 13.32 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -49.61 Mn |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 19.81 Mn |
| Mar 31, 2023 | 15.36 Mn |
| Dec 31, 2022 | 81.91 Mn |
| Sep 30, 2022 | 40.41 Mn |
| Jun 30, 2022 | 49.86 Mn |
| Mar 31, 2022 | 46.93 Mn |
| Dec 31, 2021 | 22.12 Mn |
| Sep 30, 2021 | 33.50 Mn |
| Jun 30, 2021 | 36.23 Mn |